Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act--Compliance Policies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 28, 2023
November 5, 2024
81e414c7-4ee9-4a96-aba3-257bbafce4bd
Related Documents
Requirements for Transactions with First Responders under Section 582 of the Federal Food, Drug, and Cosmetic Act— Compliance Policy Guidance for Industry
Guidance DocumentFebruary 29, 2016Center for Drug Evaluation and Research
Exemption and Exclusion From Certain Requirements of the Drug Supply Chain Security Act for the Distribution of FDA-Approved Naloxone Products During the Opioid Public Health Emergency Guidance for Industry
Guidance DocumentSeptember 22, 2022Center for Drug Evaluation and Research
COVID-19: Developing Drugs and Biological Products for Treatment or Prevention: Guidance for Industry
Guidance DocumentNovember 24, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.